Join CENTOGENE at the BioValley Basel – Annual Event to get an inside look into how we are addressing patient needs, validating therapeutic targets, and addressing regulatory pathways and clinical data sets.
This year’s event will focus on rare diseases and the unique challenges that stakeholders are faced with. Don’t miss out as CENTOGENE CEO Kim Stratton sits down to share her experiences alongside other industry leaders in the rare disease sector.
Roundtable
Title: Rare Diseases and Orphan Drugs – A Fascinating Pharma Subset
CENTOGENE Speaker: Kim Stratton
We can’t wait to see you there as we work together to deliver data-driven, life-changing answers to rare and neurodegenerative disease patients around the world!
